MedPath

Chronic Postoperative Pain After Laparoendoscopic Groin Hernia Repair

Completed
Conditions
Chronic Pain
Postoperative Pain
Registration Number
NCT04838028
Lead Sponsor
Karolinska Institutet
Brief Summary

The study attempts to quantify the relative risks for chronic postoperative inguinal pain (CPIP) depending on different combinations of mesh and mesh fixation. For this purpose the investigators will analyze data from the Swedish Hernia Registry (SHR).

Detailed Description

This is an open cohort study design where the investigators will analyze existing data that have been prospectively collected in the Swedish Hernia Registry (SHR), which covers \> 95% of all groin hernia repairs in Sweden. The very large cohort of approximately 25,000 primary TEP (totally extraperitoneal) and TAPP (transabdominal preperitoneal) repairs enable assessment of the relative risks for CPIP depending on different combinations of mesh and mesh fixation. Each participant was entered at the date of surgery when demographic and intraoperative data were registered. The possible presence of CPIP after 1 year postoperative was evaluated with a PROM questionnaire.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15360
Inclusion Criteria

All laparoendoscopic repairs for groin hernia that have been registered in the SHR from September 1, 2012, until December 31, 2018.

Exclusion Criteria
  • Open repairs.
  • Hernioplasties that were converted from laparoscopic to open surgery.
  • Bilateral repairs.
  • Surgery merely for hernia (eg obturator) other than lateral, medial or femoral.
  • Age < 15 years.
  • Patients not having a 10-digit state-assigned Patient Identification Number.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relative risk for postoperative pain at 1 year1 year

Chronic postoperative inguinal pain, measured by the Short Form Inguinal Pain Questionnaire (sf-IPQ)

Secondary Outcome Measures
NameTimeMethod
Reoperation1-8 years

Reoperation due to recurrence, during the study period

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.